Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 34.66m |
Free float | 26.34m |
P/E (TTM) | -- |
Market cap | 77.64m USD |
EPS (TTM) | -0.8864 USD |
--
More ▼
Announcements
- FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly
- FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics
- FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
- FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology
- FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024
- FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases
- FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office
- FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit
- FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa
- FibroBiologics Engages Southern Star Research as CRO in Australia
More ▼